Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.5ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BQ.1.1.8ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
CH.1.1.6ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.2.3ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.5.1.5ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
CH.1.1.15ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.5.2.20ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BN.1.3ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.5.1.22ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.2.75ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BF.5ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
CH.1.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BF.7.6ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.4.6.5ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.2.12.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
B.1.398ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
B.1.258.4ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
B.1.258.17ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
B.1.473ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
B.1.494ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
B.1.1.515ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
FL.13.3.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
B.1.177.70ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
B.1.357ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
AH.3ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
B.1.177.35ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.2.33ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
A.27ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-4790.07Japan
BF.5ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-4790.07Japan
B.1.160.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-4838.81South Korea
B.1.160.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-4838.81South Korea
XBB.2.7.1NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4848.65Thailand
XBB.1.5.8NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4848.65Thailand
BT.2NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4848.65Thailand
BA.1.12NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4848.65Thailand
BR.2NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4848.65Thailand
GJ.5NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4848.65Thailand
LB.1.7NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4848.65Thailand
XBB.1.5.11NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4848.65Thailand
XBB.1.37.1NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4848.65Thailand
HK.3.14NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4848.65Thailand
DJ.1.2NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4848.65Thailand
BA.5.1.36NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4848.65Thailand
BC.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-4850.04Japan
B.1.1.112SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-4850.04Japan
B.1.177.49SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-4850.04Japan
BF.1.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-4850.04Japan
BA.5.2.20SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-4850.04Japan
BA.5.2SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-4850.04Japan
BA.4.6.5SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-4850.04Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used